TARRYTOWN, N.Y.--(BUSINESS WIRE)--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that it has named Walter M. Capone, to the newly created position of Vice President, Commercial Development and Operations. Additionally, Nicole S. Williams has been appointed to the Company’s Board of Directors.
